United Therapeutics Corporation
$572.20
$9.02(-1.55%)
United Therapeutics Corporation
UTHR
$572.20
$9.02(-1.55%)
United Therapeutics Corporation
UTHR
NASDAQ
$572.20
$9.02(-1.55%)
Chart
Upcoming Earnings
Next report date
May 6, 2026
Report period
Q2 2026
EPS Estimate
$7.00
Revenue Estimate
$797.40M
Key stats
52-Week Range$572.20
$272.12
$607.89
Market capitalization
$25.08BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
18.93Basic EPS (TTM)
$30.13Net income (TTM)
$1.33BRevenue (TTM)
$3.18BAvg. volume
524.64KBeta (1Y)
0.60Employees
1.31KMarket capitalization
$25.08BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
18.93Basic EPS (TTM)
$30.13Net income (TTM)
$1.33BRevenue (TTM)
$3.18BAvg. volume
524.64KBeta (1Y)
0.60Employees
1.31KScreener Quick Check
Sign in to check this stock against your screeners
Sign InAbout United Therapeutics Corporation
Sector
Healthcare
Industry
Biotechnology
CEO
Martine A. Rothblatt
Website
www.unither.comHeadquarters
1040 Spring Street, Silver Spring, MD, 20910
IPO Date
1999-06-17
Identifiers
ISIN
US91307C1027Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address...
Related Stocks
$175.30
1D:
4.2%
1Y:
10.9%
US09062X1037Healthcare
Mkt Cap
$25.72B
P/E Ratio TTM
20.1
Revenue TTM
$9.81B
Beta
0.16
Earnings TTM
$1.29B
Dividend Yield TTM
0.00%
$309.97
1D:
3.3%
1Y:
46.9%
US9553061055Healthcare
Mkt Cap
$21.90B
P/E Ratio TTM
39.9
Revenue TTM
$3.22B
Beta
1.15
Earnings TTM
$542.70M
Dividend Yield TTM
0.29%
Dividend Overview
This company does not pay dividends
Financials
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q2 '26
Actual
Estimate
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q2 '26
Actual
Estimate